|
 Click on the icon to download Podcast information as a PDF file.
|
 |
|
|
E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development
Date:7/30/2008
|
Length: 00:16:44
|
Size: 7.66MB
|
Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace
In this episode, Mr. Porter, a 2008 PharmaVOICE 100 honoree, talks about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.
_____________________________________________________________________
Insights on Developing a Career Path in the New Era of the Life Sciences
Date:7/30/2008
|
Length: 00:15:08
|
Size: 6.93MB
|
Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.
In this episode, Mr. Weisman, a 2008 PharmaVOICE 100 honoree, discusses how to maximize career opportunities in the pharmaceutical industry and how career paths are changing.
_____________________________________________________________________
Mobile Devices: Connecting Physicians and Pharma
Date:7/15/2008
|
Length: 00:10:38
|
Size: 4.87MB
|
Thought Leader: Sandeep Shah, President and Founder, Skyscape
In this episode, Mr. Shah, a 2008 PharmaVOICE 100 honoree, discusses the importance of wireless mobile devices to physicians and how attitudes have changed about new media in a clinical setting. He also shares how companies can leverage this platform for improving physician communications and brand awareness.
Free Report: Effect of PDA-Based Information on Treatment Decisions
_____________________________________________________________________
Patient Journey Marketing™ and the Power of Video
Date:7/8/2008
|
Length: 00:17:52
|
Size: 8.32MB
|
Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer
In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.
Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line
_____________________________________________________________________
Improving Clinical Operations at AstraZeneca
Date:6/27/2008
|
Length: 00:16:09
|
Size: 7.39MB
|
Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals
Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.
_____________________________________________________________________
A Dual-Degree MSPharm/MBA Online Program for Life-Sciences Professionals
Date:6/16/2008
|
Length: 00:09:10
|
Size: 4.2MB
|
Thought Leader: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida
In this episode, Professor Brushwood provides an overview of a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements.
_____________________________________________________________________
Stiefel’s Dedication to Corporate Philanthropy
Date:6/19/2008
|
Length: 00:10:59
|
Size: 5.09MB
|
Thought Leader: Lyra Myers, Senior Global Category Manager, Stiefel Laboratories
In this episode, Taren Grom, Editor of PharmaVOICE, speaks with Lyra Myers about Stiefel’s many activities in corporate philanthropy, as well as her personal commitment to worthy causes.
_____________________________________________________________________
Amgen’s Commitment to Philanthropy
Date:6/13/2008
|
Length: 00:08:46
|
Size: 4.01MB
|
Thought Leader: Eduardo Cetlin, Senior Manager of Corporate Contributions, Amgen
In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Eduardo Cetlin, who discusses the Amgen Foundation, how Amgen encourages employees to become involved in volunteerism, his favorite service endeavors, and the overall goal of Amgen's philanthropic efforts.
_____________________________________________________________________
A Personal Dedication to Volunteerism and Mentoring
Date:6/13/2008
|
Length: 00:12:44
|
Size: 5.82MB
|
Thought Leader: Sherrie Pietranico, Ph.D., Research Leader, Roche
In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Dr. Pietranico about her volunteer activities educating elementary school children about science, and how the Roche internship program helped one student become a successful scientist in the pharmaceutical industry.
_____________________________________________________________________
|
Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model
Date: 6/5/2008
|
Length: 00:06:39
|
Size: 3.04MB
|
Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting
In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.
|
|
|
Redefining the CRO
Date: 5/7/2008
|
Length: 00:13:29
|
Size: 6.17MB
|
Thought Leaders: Bob Burford Ph.D., Managing Director, Aptuit Consulting
In this episode, we discuss the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.
_____________________________________________________________________
Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches
Date: 5/6/2008
|
Length: 00:10:33
|
Size: 4.83MB
|
Thought Leaders: Stan Bernard, M.D., MBA, President, Bernard Associates LLC
Dr. Bernard discusses the underutilized concept of Counter Launch Planning (CLP) for protecting an established brand, including what it is, why it's important, who participates in the process, how it differs from traditional marketing and war games, and finally, important execution considerations.
_____________________________________________________________________
The Clinical Data Liaison: The Key to Better, Faster Clinical Trials
Date: 5/5/2008
|
Length: 00:05:40
|
Size: 2.59MB
|
Thought Leaders: John Hudak, President and Founder, Criterium Inc.
In this episode, John Hudak discusses the unique and innovative role of the Clinical Data Liaison.
_____________________________________________________________________
Transform While You Perform: The Next Generation of Clinical Operations
Date: 5/5/2008
|
Length: 00:06:47
|
Size: 3.10MB
|
Thought Leaders: Nagaraja Srivatsan, Head of Life Sciences, North America, Cognizant and Kaushik Bhaumik, Global Practice Leader, Consulting and BPO, Cognizant
In this episode, out thought leaders discuss strategies to improve the drug development process.
_____________________________________________________________________
"Glocalisation" – A New Approach for Global Clinical Trials
Date: 5/5/2008
|
Length: 00:06:25
|
Size: 2.94MB
|
Thought Leaders: Amanda Decoker, Account Manager, MediciGlobal
In this episode, Amanda Decoker discusses a new approach to global clinical trials with a concept called "Glocalisation."
_____________________________________________________________________
Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation
Date: 4/30/2008
|
Length: 00:10:58
|
Size: 5.02MB
|
Thought Leaders: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing LLC
This Podcast covers several issues related to starting the marketing sequence earlier in the development cycle, including the differences between precommercial marketing and traditional product marketing, who the stakeholders are, what the necessary activities are, and some best practices for these activities.
Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
_____________________________________________________________________
Making it Stick – How Can Patient Education Really Make a Difference
Date: 4/30/2008
|
Length: 00:11:50
|
Size: 5.42MB
|
Thought Leaders: Dr. Stanley Wulf, Chief Medical Officer, InfoMedics, and Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)
This Podcast covers several key issues related to patient education and patient adherence, including who the key players are, what they can do to improve patient education, and what the pharmaceutical companies can do to raise the effectiveness of patient education.
_____________________________________________________________________
Late-Phase Research Success: Leveraging Secondary Data
Date: 4/28/2008
|
Length: 00:16:02
|
Size: 7.34MB
|
Thought Leaders: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 Innovus
This Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.
_____________________________________________________________________
Enhancing Global Market Access Strategies with Named Patient Programs
Date: 4/23/2008
|
Length: 00:12:14
|
Size: 5.60MB
|
Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS
This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.
Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
_____________________________________________________________________
The Future of Pharma CRM
Date: 4/22/2008
|
Length: 00:15:43
|
Size: 7.19MB
|
Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.
This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.
Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."
_____________________________________________________________________
|
Silo Busting – New Approaches to Brand Development
Date: 4/2/2008
|
Length: 00:09:13
|
Size: 4.21MB
|
Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident & Managing Partner, Brand Strategy & Client Services, Guard Dog Brand Development LLC
This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.
|
_____________________________________________________________________
Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008
Date: 3/20/2008
|
Length: 00:06:37
|
Size: 3.03MB
|
Event Representative: Dr. Paul M. Krueger, Associate Dean for Academic Affairs, at the UMDNJ School of Osteopathic Medicine in New Jersey
Dr. Krueger provides an overview of an upcoming, day-long seminar focused on the diagnosis and treatment of medical disorders: Fundamentals of Clinical Practice. This is the first in a series of instructional forums called Medical Education for Pharmaceutical Professionals, also known as MEPP. The first seminar will be held May 6, 2008, in New Jersey.
For seminar information and registration, click here.
|
|
_____________________________________________________________________
The Unique Challenges and Opportunities in Emerging Markets: Seizing Potential in the New High-Growth Countries
Date: 2/26/2008
|
Length: 00:16:29
|
Size: 7.55MB
|
Thought Leader: Stephen Potts, Regional Director for Healthcare – Asia Pacific, the Middle East and Africa, TNS Healthcare
Opportunities in emerging markets are numerous and challenging. This episode provides vital information on maximizing opportunities in the BRIC markets as well as the N-11 countries.
|
|
_____________________________________________________________________
Regulatory Concerns in Named Patient Programs
Date: 2/19/2008
|
Length: 00:15:01
|
Size: 6.87MB
|
Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDIS
This is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program.
|
|
_____________________________________________________________________
Named Patient Programs: An Overview
Date: 2/5/2008
|
Length: 00:18:17
|
Size: 8.37MB
|
Thought Leader: Natalie Douglas, CEO, IDIS
In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.
|
|
_____________________________________________________________________
Women's Leadership: A Personal Journey
Date: 2/1/2008
|
Length: 00:16:19
|
Size: 7.74MB
|
Thought Leaders: Meryl Zausner, CFO and VP, Novartis Oncology and 2007 HBA Woman of the Year, and Carleen Kelly, President, Surge Worldwide Healthcare Communications
HBA's "Woman of the Year" Meryl Zausner reads a "Lettter to my Younger Self" and discusses her leadership journey as a top ranking executive in the healthcare industry. Listen as she and Carleen Kelly discuss how women can maximize their career opportunities in healthcare. This Podcast episode accompanies a special publication based on The Healthcare Businesswomen's Association's (HBA) 5th Annual Leadership Conference entitled "Building World-Class Leadership" sponsored by Surge Worldwide Healthcare Communications.
|
|
_____________________________________________________________________
Navigating the Formulary Market
Date: 2/1/2008
|
Length: 00:14:26
|
Size: 6.60MB
|
Thought Leader: Jeff Thomas, President, inVentiv Strategy & Analytics
In this episode, Mr. Thomas discusses ways to develop effective formulary plans for new drugs and existing drugs with new indications, how to identify formulary opportunities, ways to use competitive intelligence in the plan development process, how brand managers can avoid common mistakes, and the best ways to communicate a plan to formulary decision makers.
|
|
_____________________________________________________________________
MSLs: An Evolving Specialty
Date: 1/24/2008
|
Length: 00:09:58
|
Size: 4.56MB
|
Thought Leader: Robin L. Winter-Sperry, M.D., President and CEO of Scientific Advantage LLC and MSL Advantage LLC
In this episode, Dr. Robin Winter-Sperry, President and CEO of Scientific Advantage LLC and MSL Advantage LLC, talks about the evolving role of the medical science liaison (MSL), return on education, how MSLs are improving patient outcomes, the growing trend of the inclusion of MSLs by emerging companies, and best practices for MSLs working in virtual teams.
Related Event: The Good, The Bad, and The Emerging:
A Medical Affairs Leadership Conference
May 1 - May 2, 2008. Bridgewater Marriott, Bridgewater, N.J.
Link: http://www.scientificadvantage.com
|
|
Own It: Transforming Public Perception of Pharma through Better Sales & Marketing Practices
Date: 11/14/2007
|
Length: 00:14:53
|
Size: 6.81MB
|
Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics
In this episode, Dr. Ball and Mr. LeVine talk about three key areas of brand management: public perception, principal stakeholders, and technology in sales and marketing practices.
|
|
Precommercial Marketing and Planning: Laying the Ground Work for Future Success
Date: 10/23/2007
|
Length: 00:14:53
|
Size: 6.81MB
|
Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing
Ms. Lucas provides details on how to develop an informed view of the market for your brand during the precommercialization phase. The discussion covers the risks for not doing so, the benefits of a prelaunch strategy, and the tactics for ultimate success.
|
|
Top Organization Leaders Speak Out at Biotech 2007
Date: 10/8/2007
|
Length: 00:34:44
|
Size: 15.9MB
|
Thought Leaders: Jim Greenwood, President and CEO, BIO, Mark Leahey, Executive Director, Medical Device Manufacturers Association, and Billy Tauzin, President and CEO, PhRMA
In this episode, Taren Grom, PharmaVOICE magazine's Editor-in-Chief chats with three of the industry's association leaders about the primary challenges their organizations' member companies face, and how the organizations can work together to impact new legislation and ultimately greater health care.
|
|
Competitive Simulations: The New, Improved War Games
Date: 9/7/2007
|
Length: 00:12:57
|
Size: 5.93MB
|
Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC
Dr. Bernard highlights the differences between competitive simulations and traditional business war games and discusses how customized competitive simulation exercises can provide strategic advantages for pharmaceutical brands and brand teams.
|
|
The Brave New Real World: A Changing Paradigm for Documenting Product Value and Safety Postapproval
Date: 8/29/2007
|
Length: 00:15:30
|
Size: 6.96MB
|
Thought Leader: Jeff Trotter, Senior VP, Lifecycle Sciences Group, Icon Clinical Research
Jeff Trotter speaks about the need for real-world value and safety in postmarketing research, the current landscape, designing new studies, and how the industry can leverage opportunities in the postapproval environment.
|
|
ePRO's Impact on Clinical Trials
Date: 8/27/2007
|
Length: 00:12:14
|
Size: 5.60MB
|
Thought Leader: Jean Paty, Ph.D., Founder and Senior VP, Scientific, Quality and Regulatory Affairs, invivodata
Dr. Paty talks about a defining moment in clinical trial data, how ePRO will revolutionize clinical trials, improving the adoption of ePRO, and the future of clinical data technology.
|
|
Incorporating Electronic Health Records in the Trial Process
Date: 8/27/2007
|
Length: 00:17:54
|
Size: 8.19MB
|
Thought Leader: James Rogers, CEO, Nextrials Inc.
Taren Grom, Cofounder and Editor of PharmaVOICE magazine, and James Rogers, CEO of Nextrials, discuss the benefits of incorporating electronic health records (EHR) into the clinical-trial process, what the challenges are, and how EHR can be used in other areas, such as patient recruitment.
|
|
Managing Chargebacks to Boost the Bottom Line
Date: 8/17/2007
|
Length: 00:19:23
|
Size: 8.87MB
|
Thought Leader: Al Godley, Director of Life-Science Solutions, Edge Dynamics
Al Godley explains the impact that chargebacks have on manufacturers' bottom lines, why chargebacks continue to be a source of silent revenue leakage, and best practices for chargeback management.
|
|
Translational Connection Model for Creating Infectious Disease Therapies:
Part 1
Date: 8/10/2007
|
Length: 00:16:49
|
Size: 7.70MB
|
Thought Leader: Barry Eisenstein, M.D., Senior VP, Scientific Affairs, Cubist Pharmaceuticals
Taren Grom, Cofounder and Editor of PharmaVOICE, and Dr. Eisenstein discuss the concept of a "translational connection" development model and how this shift in thinking can be employed to create new therapies to address unmet medical need in infectious disease in Part 1 of a 2-part series.
| | | |
Subscribe to the PharmaVOICE Podcasts RSS feed!
